Dargantes, Bonifacio T.

HRN: 24-97-19  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2024
CEFTRIAXONE 1G (VIAL)
05/03/2024
05/10/2024
IV
2g
Q24
Infected Wound
Waiting Final Action 
05/03/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/03/2024
05/10/2024
IV
300mg
Q8
Infected Wound
Waiting Final Action 
05/03/2024
SODIUM FUSIDATE 20MG/G, 15G OINTMENT
05/03/2024
05/10/2024
IV
15g
OD
Infected Wund
Waiting Final Action 
05/04/2024
AZITHROMYCIN 500MG TABLET (TAB)
05/04/2024
05/10/2024
ORAL
500mg
OD
CAP MR
Waiting Final Action 
05/05/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/05/2024
05/05/2024
IVT
4.5g
To Run In 4hrs As Loading Dose
Infected Wound, Right Foot
Waiting Final Action 
05/05/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/05/2024
05/12/2024
IVT
2.25g
Q6
Infected Wound, Right Foot
Waiting Final Action 
05/06/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/06/2024
05/13/2024
IV
Topical
BID
Infected Wound
Waiting Final Action 
05/13/2024
CEFTRIAXONE 1G (VIAL)
05/13/2024
05/20/2024
IV
2g
OD
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: